RecruitingPhase 2NCT05708352
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
Studying Embryonal tumor of neuroepithelial tissue
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cedars-Sinai Medical Center
- Principal Investigator
- Jethro Hu, MDCedars-Sinai Medical Center
- Intervention
- Keto Diet(behavioral)
- Enrollment
- 170 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2029
Study locations (5)
- Cedars-Sinai Medical Center, Los Angeles, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Pacific Neuroscience Institute / Saint John's Cancer Institute, Santa Monica, California, United States
- Duke University, Durham, North Carolina, United States
- Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05708352 on ClinicalTrials.govOther trials for Embryonal tumor of neuroepithelial tissue
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07488754Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)Medical University of Warsaw
- RECRUITINGPHASE1NCT07025018Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 MutationsHutchmed
- RECRUITINGNANCT06719440Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target VolumeCliniques universitaires Saint-Luc- Université Catholique de Louvain
- RECRUITINGPHASE2NCT06558214OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd TrialUniversity of Florida
- RECRUITINGPHASE3NCT06496971A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme PatientsNaviFUS Corporation
- RECRUITINGPHASE2NCT07364786Effect of Salovum® on Pressure, Oxygen and Inflammation in GlioblastomaPeter Siesjö
- RECRUITINGEARLY PHASE1NCT06828341A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 ExpressionJIANG LONGWEI
- RECRUITINGPHASE1NCT05030298Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma TrialMayo Clinic
See all trials for Embryonal tumor of neuroepithelial tissue →